- cafead   Mar 19, 2024 at 12:12: PM
via Engrail Therapeutics has closed a nine-digit series B to further its neuropsychiatric pipeline, the latest evidence that investors are flocking to fund new treatments in this resurgent therapeutic area.
article source
article source